GUJRATHI SHEILA
SEC CIK 1575202 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| JANX | Janux Therapeutics, Inc. | Dir | 118.9K | — | — | 4 | 2024-02-29 | 2025-06-11 |
Most active insiders at JANX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Meyer Andrew Hollman | Chief Business Off | — | $736.7K |
| 2 | Campbell David Alan | Pres, CEO, Dir | — | $110.8K |
| 3 | Doyle Janeen Noel | Chief Corp, Bus. Dev. Ofcr | — | $56.9K |
| 4 | Dobek Maria | VP, Accounting | — | $49.0K |
| 5 | McIver Zachariah | Chief Medical Off | — | $37.3K |
| 6 | DiRaimondo Thomas | CSO | — | $34.4K |
| 7 | Winter Charles M. | Chief Technical Off | — | $33.0K |
| 8 | Go William | Chief Medical Off | — | — |
| 9 | Simson Jake | Dir | — | — |
| 10 | Hernday Natasha | Dir | — | — |
GUJRATHI SHEILA made no open-market trades at JANX in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-13 | 2025-06-11 | JANX | Janux Therapeutics, Inc. | Gujrathi Sheila | Dir | A - Grant | $0.00 | +3,750 | 118.9K | +3% | $0 |
| 2024-11-07 | 2024-11-05 | JANX | Janux Therapeutics, Inc. | Gujrathi Sheila | Dir | J - Other | $0.00 | +4,611 | 115.1K | +4% | $0 | |
| D | 2024-06-28 | 2024-06-26 | JANX | Janux Therapeutics, Inc. | Gujrathi Sheila | Dir | A - Grant | $0.00 | +2,500 | 110.5K | +2% | $0 |
| 2024-03-04 | 2024-02-29 | JANX | Janux Therapeutics, Inc. | Gujrathi Sheila | Dir | J - Other | $0.00 | +2,986 | 108.0K | +3% | $0 |
Purchase Sale Sale after option exercise All abbreviations